Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
CHEMISTRY AND IMMUNOASSAY TESTING SUPPLIES is a federal award for Defense Health Agency held by Roche Diagnostics Corp. Estimated value $227K ($227K obligated). Current period of performance ends Mar 26, 2026. Place of performance: BETHESDA MD.
CHEMISTRY AND IMMUNOASSAY TESTING SUPPLIES
Recompete timing
PublicCurrent PoP ended Mar 26, 2026 (148 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT001426FE030?
HT001426FE030 (Chemistry and immunoassay testing supplies) is a Defense Health Agency award with a potential value of $227K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded HT001426FE030?
Defense Health Agency awarded HT001426FE030 to Roche Diagnostics Corp (potential $227K).
Who is the incumbent on HT001426FE030?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Mar 26, 2026.
When does Roche Diagnostics Corp’s HT001426FE030 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 26, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
